Blog Collection

Blog Hero Image

Encouraging Results in Early Clinical Trials of Possible Treatment

Concert Pharmaceuticals, Inc. made a dramatic announcement regarding the encouraging results of a possible alopecia areata treatment referred to as CTP-543, a modified version of the blood disorder treatment ruxolitinib commercially known as Jakafi®. Learn More